Filing Flows › Teladoc Health (TDOC) › Q2 2026
Teladoc Health (TDOC) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 30, 2026
Teladoc Health (TDOC) reported revenue of $607M for the second quarter 2026 (Q2 2026), -4% from a year earlier and -1% from the quarter before. Operating margin was -6.1%, net loss $38.9M (6.4% of revenue).
Teladoc Health, Q2 2026: revenue $607M (-4% year over year), operating margin -6.1%, net loss $38.9M, operating cash flow $64.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $607M | -1% | -4% |
| Operating profit | −$37.1M | — | — |
| Net earnings | −$38.9M | — | — |
| Operating cash flow | $64.7M | +580% | -29% |
| Free cash flow | $63.7M | +711% | -29% |
What changed
Revenue was $606.9M in Q2 2026, down 4% year over year and down 1% from the previous quarter. Access Fees was the largest line at 78% of revenue. Access Fees lost $49.5M year over year (down 9%), 198% of the total change.
Operating costs exceeded revenue by $37.1M, an operating margin of -6.1%. Total costs fell 6% while revenue fell 4%. The quarter ended with a net loss of $38.9M, narrower than the previous quarter's $63.8M loss.
Operating cash flow was $64.7M (down 29% year over year). Non-cash charges added back $9.3M of share-based compensation. Working capital and other items added $94.3M. Capital expenditures of $928K left free cash flow of $63.7M.
Questions
What was Teladoc Health's revenue in the second quarter 2026?
Teladoc Health (TDOC) reported revenue of $607M for the second quarter 2026 (Q2 2026), -4% from a year earlier and -1% from the quarter before.
Was Teladoc Health profitable in the second quarter 2026?
Operating loss was $37.1M (-6.1% of revenue) and net loss $38.9M.
Source: Teladoc Health 10-Q on SEC EDGAR.